Your session is about to expire
← Back to Search
Other
Ankle Exoskeleton Assistance for Aging
N/A
Waitlist Available
Led By Gregory S Sawicki, Ph.D.
Research Sponsored by Georgia Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial is testing if an ankle exoskeleton can help reduce the amount of energy older adults use when walking, in order to understand why older adults use more energy when walking than young adults.
Who is the study for?
This trial is for healthy adults who can walk for an hour within a 90-minute period. It's open to two age groups: young adults aged 18-45 and seniors aged 65 or older, without cardiovascular, metabolic, renal diseases, musculoskeletal injuries, or respiratory problems.Check my eligibility
What is being tested?
The study aims to understand why older adults use more energy while walking compared to younger ones and attempts to reduce this energy expenditure using an ankle exoskeleton device that enhances muscle contractions during walking.See study design
What are the potential side effects?
While the trial does not mention specific side effects of using the ankle exoskeleton, potential risks may include discomfort at the site of wearing the device or muscle fatigue due to altered walking patterns.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Metabolic rate (watts)
Secondary outcome measures
Preferred walking speed (m/s)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Economical muscle dynamicsExperimental Treatment1 Intervention
The investigators are trying to figure out how to optimize muscle contractile conditions for mobility. To do this, the investigators are systematically altering muscle contraction conditions for all participants.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strengthening muscle contractions during walking
2020
N/A
~30
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,086 Total Patients Enrolled
160 Trials studying Aging
75,979 Patients Enrolled for Aging
Georgia Institute of TechnologyLead Sponsor
48 Previous Clinical Trials
5,506 Total Patients Enrolled
4 Trials studying Aging
236 Patients Enrolled for Aging
Gregory S Sawicki, Ph.D.Principal InvestigatorGeorgia Institute of Technology
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have an abnormal heart sound called a heart murmur.You have a pacemaker implanted.You do not have any current injuries to your bones or muscles.You have a history of feeling dizzy or having problems with balance.You have asthma.You have issues with your heart, metabolism, kidneys, or breathing.You are either under 18 or between 46 and 64 years old.You smoke cigarettes.You have trouble breathing when lying down or at night.You experience chest, neck, jaw, or arm pain or discomfort during rest or physical activity.You experience fast or irregular heartbeats.You have a muscle or bone injury or experience walking pain.You are experiencing swelling in your ankles.You experience unusual shortness of breath during normal activities.You have had a heart attack.
Research Study Groups:
This trial has the following groups:- Group 1: Economical muscle dynamics
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research study still recruiting participants?
"This clinical trial, which was initially posted on February 4th 2020 and recently updated on August 18th 2022, is looking for participants. All pertinent information can be found at the website of clinicaltrials.gov."
Answered by AI
How many participants have been recruited for this investigation?
"Affirmative. According to clinicaltrials.gov, this experiment is still taking in new participants since it was posted on February 4th 2020 and last amended on August 18th 2022. The research team seeks 30 persons from one medical center for the trial."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger